02068nas a2200217 4500000000100000008004100001260003400042100001400076700001200090700001500102700001100117700001100128700001200139700001400151700001400165700001000179245007800189856011000267520144800377022002501825 2025 d bOxford University Press (OUP)1 aPandey DK1 aAlvar J1 aden Boer M1 aJain S1 aGill N1 aArgaw D1 aSalunke S1 aHussain M1 aRoy N00aKala-azar elimination in India: reflections on success and sustainability uhttps://academic.oup.com/inthealth/advance-article-pdf/doi/10.1093/inthealth/ihaf013/62226751/ihaf013.pdf3 a
Abstract
The incidence and mortality of kala-azar (KA, visceral leishmaniasis) in India have fallen drastically in the past few years, and in 2023 the reported KA incidence reached the threshold for elimination as a public health problem (<1 case/10 000 of population at subdistrict level). One of the strategies adopted by India's kala-azar elimination program (KAEP) was the regular independent assessment of the program implementation by teams of experts. We present the findings of assessments undertaken in 2019, 2021 and 2023, when the KAEP was in the last mile of elimination. Factors that contributed to its success were political commitment, intensified implementation, a strong network of KA partners and committed donors. Bottlenecks were observed in disease surveillance, data utilization, vector-control operations and program management at implementation. To sustain the gains and achieve validation of elimination, the KAEP should continue the following minimal essential services: optimized active and passive case detection and management of KA, post-KA dermal leishmaniasis, KA-HIV coinfection and relapse supported by vector-control interventions. Long-term measures that will sustain elimination are overall socioeconomic development, including improved living conditions, parallel with efficient surveillance and operational research that is aligned with the changing epidemiology of the disease.
a1876-3413, 1876-3405